🕵️ REIN Therapeutics, Inc. ($RNTX)
SEC insider & ownership activity, last 12 months · CIK 1420565 · every row links its SEC filing
Insider buy value was withheld pending verification over the last 12 months. One red-flag 8-K in the window: Delisting notice (3.01), Aug 21, 2026.
Insider flow
3 buyers, value withheld pending verification (10 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| VOSS Capital, LP | 5 | value withheld pending verification | 0 | – | Nov 14, 2025 |
| Von Rickenbach Josef H. | 4 | $50K | 0 | – | May 27, 2026 |
| Windsor James Brian | 1 | $25K | 0 | – | Apr 30, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| BIOS Capital Management, LP | 10.0% | 13G | May 8, 2026 | filing ↗ | |
| BIOS Advisors GP, LLC | 10.0% | 13G | May 8, 2026 | filing ↗ | |
| CAVU Advisors, LLC | 10.0% | 13G | May 8, 2026 | filing ↗ | |
| CAVU Management, LP | 10.0% | 13G | May 8, 2026 | filing ↗ | |
| Leslie W. Kreis | 10.0% | 13G | May 8, 2026 | filing ↗ | |
| Aaron G.l. Fletcher | 10.0% | 13G | May 8, 2026 | filing ↗ | |
| Funicular Funds, LP | 6.7% | 13G | May 7, 2026 | filing ↗ | |
| Cable CAR Capital, LP | 6.7% | 13G | May 7, 2026 | filing ↗ | |
| Ma-Weaver Jacob | 6.7% | 13G | May 7, 2026 | filing ↗ | |
| VOSS Capital, LP | 6.6% | 13G | Jul 14, 2026 | filing ↗ | |
| Travis W. Cocke | 6.6% | 13G | Jul 14, 2026 | filing ↗ | |
| Benjamin Shapiro | 6.1% | 13G | May 8, 2026 | filing ↗ | |
| BIOS LTI Co-Invest III QP, LP | 5.5% | 13G | May 8, 2026 | filing ↗ | |
| BIOS LTI Co-Invest III, LP | 5.4% | 13G | May 8, 2026 | filing ↗ | |
| ADAR1 Capital Management, LLC | 5.3% | 13G | Aug 14, 2026 | filing ↗ | |
| Daniel Schneeberger | 5.3% | 13G | Aug 14, 2026 | filing ↗ | |
| Lynwood Capital Management Inc. | 5.0% | 13G | Aug 14, 2026 | filing ↗ | |
| Ben Shapiro | 5.0% | 13G | Aug 14, 2026 | filing ↗ | |
| Lynwood Opportunities Master Fund | 5.0% | 13G | Aug 14, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Sep 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 4, 2026 | filing ↗ |
| Delisting notice (3.01) | Aug 21, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jul 20, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 30, 2026 | filing ↗ |
| Other events (8.01) | Apr 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 30, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 24, 2026 | filing ↗ |
| New financial obligation (2.03) | Feb 24, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Feb 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 24, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 16, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 15, 2026 | filing ↗ |
| New financial obligation (2.03) | Jan 15, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jan 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 15, 2026 | filing ↗ |
| Agreement terminated (1.02) | Dec 11, 2025 | filing ↗ |
| Other events (8.01) | Nov 3, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 3, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 23, 2025 | filing ↗ |
| New financial obligation (2.03) | Oct 23, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Oct 23, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 23, 2025 | filing ↗ |
| Other events (8.01) | Oct 9, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 9, 2025 | filing ↗ |
| Other events (8.01) | Sep 16, 2025 | filing ↗ |